The Problem Lack of access to high-quality, affordable medical devices for hospitals and clinicians serving the world’s poor results in illness, suffering, mortality and an ever-spiraling trap of poverty. Severe jaundice is the specific problem on which D-Rev currently focuses. In industrialized countries, newborn jaundice (caused by an excess of bilirubin in the blood) is easily treated with phototherapy (a specialized intense LED blue light) and therefore rarely leads to kernicterus—a type of preventable brain damage which can occur if jaundice goes untreated. In developing countries however, effective LED phototherapy machines are not nearly as accessible, partly due to costs upwards of US$3,000. In developing countries, kernicterus ranks as the fifth leading cause of mortality in newborns. Over 6 million babies with severe jaundice are not receiving adequate treatment, according to an assessment by Stanford and D-Rev.